Stock listing

Nanoviricides, Inc.

Selected listing: NNVC · BOATS · USD · US

Nanoviricides, Inc. (BOATS:NNVC), Health Technology. Latest release Sep 15, 2026: Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week…

NNVC:BOATSUSDUSUpdated October 3, 2026
Nanoviricides, Inc. logo
Ticker
BOATS:NNVC
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

About Nanoviricides, Inc.

Nanoviricides, Inc. is a public company traded under the ticker NNVC in the American market. Nanoviricides focuses on developing antiviral therapies to combat various viral infections.

Latest news from Nanoviricides, Inc.

All Nanoviricides, Inc. news →

Research Nanoviricides, Inc.

Alternate listings